Martlet Capital Limited has invested in more than 65 start-ups, since its launch in 2011. In 2021, Martlet successfully raised additional capital to scale its investment activity. We provide patient capital for early-stage IP rich, B2B deep technology and life science start-ups, with a primary focus on companies based in Cambridge. Our team is comprised of experienced investors and entrepreneurs. Initial sums of capital of £250K are invested to help support early-stage companies. Martlet will almost always co-invest with angels and seed funds and has the capacity to follow on in subsequent investment rounds. In addition to capital, we offer support, experience and a network of contacts. Martlet typically focuses on pre-seed and seed-stage companies. Potential investees must demonstrate their potential for rapid growth and will usually possess a strong defensible position with respect to their technology, intellectual property and products. In all cases, there must be a strong and demonstratable commercial demand for the technology under development. We have achieved several exits from our portfolio, from trade sales to global technology companies and IPO’s. Please visit our website to learn more.